CT-P13 (infliximab)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CT-P13 (infliximab), covering 2020-01-13 to 2023-10-23. Get the full timeline:
Most recent: Clinical Trial Update: CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD) [Phase 3]